CS logo
small CS logo
Synexus Clinical Research

New York, New York, United States
Research institute in New York City, New York
144 E 44th St 2nd Floor, New York, NY 10017

About Synexus Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Synexus Clinical Research


During the past decade, Synexus Clinical Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Synexus Clinical Research" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Karuna Therapeutics" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Neurogastrx, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

Clinical Trials Conditions at Synexus Clinical Research


According to Clinical.Site data, the most researched conditions in "Synexus Clinical Research" are "Schizophrenia" (3 trials), "Depressive Disorder, Major" (1 trials), "Diabetic Gastroparesis" (1 trials), "Extraintestinal Pathogenic Escherichia Coli Prevention" (1 trials) and "Idiopathic Gastroparesis" (1 trials). Many other conditions were trialed in "Synexus Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Synexus Clinical Research


Most popular intervention types in "Synexus Clinical Research" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Xanomeline and Trospium Chloride Capsules" (2 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "BI 1358894" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Synexus Clinical Research


The vast majority of trials in "Synexus Clinical Research" are 7 trials for "All" genders.

Clinical Trials Status at Synexus Clinical Research


Currently, there are NaN active trials in "Synexus Clinical Research". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Synexus Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Clinical Research, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".